TY - JOUR
T1 - Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload
AU - Piquereau, Jerome
AU - Caffin, Fanny
AU - Novotova, Marta
AU - Prola, Alexandre
AU - Garnier, Anne
AU - Mateo, Philippe
AU - Fortin, Dominique
AU - Huynh, Le Ha
AU - Nicolas, Valrie
AU - Alavi, Marcel V.
AU - Brenner, Catherine
AU - Ventura-Clapier, Rene
AU - Veksler, Vladimir
AU - Joubert, Frédéric
N1 - Funding Information:
This work was partly supported by a grant VEGA 2/0116/12. This work was supported by grants from the European Union contract LSHM-CT-2005-018833/EUGeneHeart and a grant from University of Paris Sud (Attractivité). R.V.-C., C.B., and F.J. are scientists at Centre National de la Recherche Scientifique.
PY - 2012/6/1
Y1 - 2012/6/1
N2 - Aims The optic atrophy 1 (OPA1) protein is an essential protein involved in the fusion of the mitochondrial inner membrane. Despite its high level of expression, the role of OPA1 in the heart is largely unknown. We investigated the role of this protein in Opa1 /- mice, having a 50 reduction in OPA1 protein expression in cardiac tissue. Methods and resultsIn mutant mice, cardiac function assessed by echocardiography was not significantly different from that of the Opa1 /. Electron and fluorescence microscopy revealed altered morphology of the Opa1 /- mice mitochondrial network; unexpectedly, mitochondria were larger with the presence of clusters of fused mitochondria and altered cristae. In permeabilized mutant ventricular fibres, mitochondrial functional properties were maintained, but direct energy channelling between mitochondria and myofilaments was weakened. Importantly, the mitochondrial permeability transition pore (PTP) opening in isolated permeabilized cardiomyocytes and in isolated mitochondria was significantly less sensitive to mitochondrial calcium accumulation. Finally, 6 weeks after transversal aortic constriction, Opa1 /- hearts demonstrated hypertrophy almost two-fold higher (P< 0.01) than in wild-type mice with altered ejection fraction (decrease in 43 vs. 22 in Opa1 / mice, P< 0.05). Conclusion sThese results suggest that, in adult cardiomyocytes, OPA1 plays an important role in mitochondrial morphology and PTP functioning. These properties may be critical for cardiac function under conditions of chronic pressure overload.
AB - Aims The optic atrophy 1 (OPA1) protein is an essential protein involved in the fusion of the mitochondrial inner membrane. Despite its high level of expression, the role of OPA1 in the heart is largely unknown. We investigated the role of this protein in Opa1 /- mice, having a 50 reduction in OPA1 protein expression in cardiac tissue. Methods and resultsIn mutant mice, cardiac function assessed by echocardiography was not significantly different from that of the Opa1 /. Electron and fluorescence microscopy revealed altered morphology of the Opa1 /- mice mitochondrial network; unexpectedly, mitochondria were larger with the presence of clusters of fused mitochondria and altered cristae. In permeabilized mutant ventricular fibres, mitochondrial functional properties were maintained, but direct energy channelling between mitochondria and myofilaments was weakened. Importantly, the mitochondrial permeability transition pore (PTP) opening in isolated permeabilized cardiomyocytes and in isolated mitochondria was significantly less sensitive to mitochondrial calcium accumulation. Finally, 6 weeks after transversal aortic constriction, Opa1 /- hearts demonstrated hypertrophy almost two-fold higher (P< 0.01) than in wild-type mice with altered ejection fraction (decrease in 43 vs. 22 in Opa1 / mice, P< 0.05). Conclusion sThese results suggest that, in adult cardiomyocytes, OPA1 plays an important role in mitochondrial morphology and PTP functioning. These properties may be critical for cardiac function under conditions of chronic pressure overload.
KW - Cardiac energy metabolism
KW - Hypertrophy
KW - Mitochondria
KW - Mitochondrial dynamics
KW - Permeability transition pore
UR - http://www.scopus.com/inward/record.url?scp=84861385983&partnerID=8YFLogxK
U2 - 10.1093/cvr/cvs117
DO - 10.1093/cvr/cvs117
M3 - Article
C2 - 22406748
AN - SCOPUS:84861385983
SN - 0008-6363
VL - 94
SP - 408
EP - 417
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 3
ER -